GLPG News
Archived Headlines
- Natural (stock) selection: Galapagos increases proposed IPO deal size by 25% to $250 million 05/11/15
- Week ahead: 9 IPOs planned for the week of May 11 05/10/15
- Survival of the fittest biotechs: Galapagos sets terms for $160 million US IPO 05/05/15
- Belgian biotech Galapagos files for a $150 million US IPO 04/15/15
Renaissance IPO Index - Notice of September 2015 Quarterly Changes
The Renaissance IPO Index (Ticker: IPOUSA), the underlying index for the Renaissance IPO ETF (Ticker: IPO), will implement the following constituent changes at the market’s...read more
US IPO Weekly Recap: With 6 IPOs, the year's largest company goes public
Six companies went public in the past week, raising $1.4 billion. Half traded up 10% or more, and half had negative or no return. For the second week in a row, the general partner of a midstream natural gas pipelines MLP priced an upsized IPO above its...read more
Galapagos prices further upsized US listing at $42.05, raises $275 million
Galapagos, a Belgian biotech developing new treatments for inflammatory diseases, raised $275 million by offering 6.55 million shares (76% ADSs and 24% ordinary shares offered to European investors) at $42.05. The company expected to offer 6.03 million shares,...read more
Cystic fibrosis biotech Nivalis Therapeutics files for a $60 million IPO
Nivalis Therapeutics, which is developing a complementary small molecule therapy for cystic fibrosis, filed on Wednesday with the SEC to raise up to $60 million in an initial public offering. Nivalis lists several biotechs developing therapies for cystic...read more